NCT07475806 2026-03-17
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Astellas Pharma Inc
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT04660344 2026-02-13
IMvigor011
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT06686381 2025-02-05
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
Phase 2 Not yet recruiting
NCT06373055 2024-04-18
Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics
Yonsei University
Recruiting
NCT06362330 2024-04-12
Multi-parametric MRI in Patients of Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University
Recruiting
NCT03234153 2020-06-17
NITIMIB
Insel Gruppe AG, University Hospital Bern
Phase 2 Terminated